SCHEMBL4388545

SCHEMBL4388545

Cc1cccc(-c2ncc[nH]2)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.47
TYRO3 Q06418 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
NISCH Q9Y2I1 2/20 0.44
TAAR1 Q96RJ0 1/20 0.44
MTOR P42345 1/20 0.43
ADK P55263 1/20 0.43
POLB P06746 1/20 0.39
CD44 P16070 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
F2RL1 P55085 1/20 0.38
NOS3 P29474 2/20 0.37
NOS2 P35228 2/20 0.37
NOS1 P29475 1/20 0.37
IDO1 P14902 1/20 0.37
ADRA1A P35348 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14886293 0.86 CSNK1A1 (0.54) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL29483242 0.82 NISCH (0.47) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL2011486 0.82 NISCH (0.47) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL674011 0.82 NISCH (0.53) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL6001368 0.80 NISCH (0.52) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL10937921 0.79 SMN1; SMN2 (0.53) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL8540856 0.79 CSNK1A1 (0.47) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL31429657 0.79 CSNK1A1 (0.47) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL1074245 0.79 CSNK1A1 (0.47) CSNK1A1TYRO3DYRK1BNISCHTAAR1
SCHEMBL11847005 0.79 NISCH (0.44) CSNK1A1TYRO3DYRK1BNISCHTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629463-B2 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-12-08 US disclosed
US-20080132524-A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests CLARK DAVID ALAN 2008-06-05 US disclosed
US-7375232-B2 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-05-20 US disclosed
EP-1417204-B1 ORTHO-HETEROCYCLIC SUBSTITUTED ARYL AMIDES FOR CONTROLLING INVERTEBRATE PESTS DU PONT (US) 2006-01-18 EP disclosed
US-20040242645-A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests E. I. DU PONT DE NEMOURS AND COMPANY 2004-12-02 US disclosed
EP-1417204-A1 ORTHO-HETEROCYCLIC SUBSTITUTED ARYL AMIDES FOR CONTROLLING INVERTEBRATE PESTS E. I. du Pont de Nemours and Company (US) 2004-05-12 EP disclosed
WO-2003016304-A1 ORTHO-HETEROCYCLIC SUBSTITUTED ARYL AMIDES FOR CONTROLLING INVERTEBRATE PESTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132524-A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests AOC2, DDT, CBR3 CSNK1A1 2696/4885TYRO3 24/4885DYRK1B 2430/4885
US-20040242645-A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests AOC2, OLA1, AOC3 CSNK1A1 3533/4885TYRO3 658/4885DYRK1B 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.